Development
Bruker Corporation
BRKR
$33.52
-$0.12-0.36%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 427.20M | 319.10M | 319.10M | 311.50M | 296.60M |
| Total Depreciation and Amortization | 114.90M | 102.10M | 96.50M | 92.20M | 88.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -104.20M | 77.40M | 60.00M | 45.50M | 33.10M |
| Change in Net Operating Assets | -87.80M | -182.50M | -134.10M | -165.10M | -144.10M |
| Cash from Operations | 350.10M | 316.10M | 341.50M | 284.10M | 274.40M |
| Capital Expenditure | -106.90M | -110.00M | -140.80M | -135.20M | -129.20M |
| Sale of Property, Plant, and Equipment | 11.10M | 11.00M | 10.80M | 11.90M | 13.90M |
| Cash Acquisitions | -226.60M | -319.10M | -199.60M | -186.60M | -182.30M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.60M | -20.40M | -11.50M | 51.90M | 46.00M |
| Cash from Investing | -326.00M | -438.50M | -341.10M | -258.00M | -251.60M |
| Total Debt Issued | 0.00 | 3.50M | 3.00M | 300.00K | 300.00K |
| Total Debt Repaid | -21.50M | -20.80M | -15.50M | -10.70M | -111.00M |
| Issuance of Common Stock | 9.50M | 6.80M | 4.80M | 2.90M | 5.30M |
| Repurchase of Common Stock | -152.30M | -128.20M | -122.10M | -182.40M | -265.60M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -29.40M | -29.50M | -29.50M | -29.70M | -29.80M |
| Other Financing Activities | 300.00K | -1.40M | 200.00K | -9.00M | -14.50M |
| Cash from Financing | -193.40M | -169.60M | -159.10M | -228.60M | -415.30M |
| Foreign Exchange rate Adjustments | 12.20M | 29.60M | 10.60M | -15.70M | -30.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.10M | -262.40M | -148.10M | -218.20M | -423.00M |